Frequently Asked Questions
Body Contouring
Facials & Peels
Hair Restoration
Injectables
Laser Hair Removal
Other
Skin Resurfacing/Lasers
Wellness
MOTCB4211 is a mitochondrial-derived peptide being studied for its potential impact on metabolism and cellular energy.
Some individuals report redness, itching, or swelling at the injection site. Other side effects may include headache, fatigue, or nausea. Any concerning symptoms should be reported to your provider.
Research is ongoing into TB-500’s potential role in supporting cellular migration and tissue repair. Evidence is preliminary, and TB-500 is not FDA-approved for these uses.
TB-500 is usually given as a subcutaneous injection. Your provider will determine the appropriate dosing schedule and provide instructions.
TB-500 is a synthetic peptide fragment of thymosin beta-4 that is being studied for its role in tissue health and repair.
Yes, your provider may recommend periodic lab work and follow-up visits to evaluate your response and make adjustments if needed.
Side effects may include temporary injection site irritation, headache, flushing, or fatigue. Any concerning symptoms should be reported to your provider.
Sermorelin may be discussed with individuals interested in wellness goals such as recovery, energy, or healthy sleep patterns. Suitability is determined after consultation and lab work.
Research is exploring Sermorelin’s potential to support metabolism, energy, and healthy aging by encouraging growth hormone release. Evidence remains limited, and it is not FDA-approved for these uses.
Sermorelin is a peptide that stimulates the body’s natural production of growth hormone. It is administered by subcutaneous injection. Your provider will guide the dosing protocol.
Pentadeca Arginate is not FDA-approved for medical use. It is available through licensed medical providers for investigational and compounded use. At Elase, all therapies are prescribed and monitored under medical supervision.
Research is ongoing into Pentadeca Arginate’s potential role in supporting tissue repair and post-activity recovery. Evidence is preliminary, and it is not an FDA-approved treatment for any medical condition.
